Torrey Pines Investment logo

Torrey Pines Investment

North America, California, United States, San Diego

Description

Torrey Pines Investment, established in 2002 and headquartered in San Diego, California, is a specialized venture capital firm dedicated to the life sciences sector. The firm primarily focuses on early-stage companies within biotechnology, medical devices, diagnostics, and pharmaceuticals. With over two decades of experience, Torrey Pines Investment leverages the deep scientific and business expertise of its managing directors, Dr. David Kabakoff and Dr. Michael Kabakoff, to identify and nurture promising ventures in the highly complex and regulated life science industry.

The firm's investment strategy is characterized by its hands-on approach, aiming to be more than just a capital provider. Torrey Pines Investment actively engages with its portfolio companies, offering strategic guidance, operational support, and access to their extensive network. This collaborative model is designed to help early-stage companies navigate the challenges of product development, clinical trials, and market entry, ultimately accelerating their growth and increasing their probability of success. Their commitment extends to helping entrepreneurs transform innovative scientific discoveries into viable commercial products.

Torrey Pines Investment typically participates in seed and Series A funding rounds. For initial investments, the firm generally writes checks ranging from $500,000 to $2,000,000. This targeted investment size allows them to provide meaningful capital to nascent companies while maintaining a focused portfolio. According to Crunchbase, Torrey Pines Investment has made at least 13 investments since its inception, demonstrating a consistent commitment to the life science ecosystem.

The firm's long-standing presence in the San Diego biotech hub, a renowned cluster for life science innovation, provides them with a strategic advantage in sourcing deals and collaborating with key industry players. While their primary focus is on early-stage opportunities, their involvement often extends through subsequent funding rounds, supporting companies as they mature. Torrey Pines Investment's disciplined approach and specialized focus position them as a key partner for life science entrepreneurs seeking not only capital but also experienced guidance to bring their groundbreaking technologies to market.

Investor Profile

Torrey Pines Investment has backed more than 28 startups, with 6 new investments in the last 12 months alone. The firm has led 6 rounds, about 21% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series Unknown, Convertible Note rounds (top funding stages).
  • Majority of deals are located in United States, Russian Federation, The Netherlands.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
  • Led 2 rounds in the past year.
  • Typical check size: $500K – $2M.

Stage Focus

  • Seed (43%)
  • Series Unknown (25%)
  • Convertible Note (11%)
  • Pre Seed (11%)
  • Series B (7%)
  • Series A (4%)

Country Focus

  • United States (75%)
  • Russian Federation (7%)
  • The Netherlands (7%)
  • Canada (4%)
  • Finland (4%)
  • Zambia (4%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Life Science
  • Therapeutics
  • Oncology
  • Real Time
  • Biopharma
  • Fitness
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Torrey Pines Investment frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Business Finland
Europe, Southern Finland, Finland, Helsinki
Co-Investments: 1
TealTech Capital
Europe, Moscow City, Russian Federation, Moscow
Co-Investments: 1
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 1
Avalon Ventures
North America, California, United States, La Jolla
Co-Investments: 2
WuXi Healthcare Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
BioGeneration Ventures
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 1
WuXi AppTec
Asia, Shanghai, China, Shanghai
Co-Investments: 1
CL
Europe, Moscow City, Russian Federation, Khimki
Co-Investments: 1
Skolkovo Foundation
Europe, Moscow City, Russian Federation, Moscow
Co-Investments: 1

What are some of recent deals done by Torrey Pines Investment?

MAIR PHARMACEUTICALS

Lusaka, NA - Zambia, Zambia

Mair Pharma provides pharmaceutical services, development.

ManufacturingPharmaceutical
Pre SeedFeb 13, 2025
Mair Therapeutics

Nijmegen, Gelderland, The Netherlands

Mair Therapeutics is pioneering therapies for Parkinson's disease.

BiopharmaBiotechnologyClinical TrialsPersonal Development
Pre SeedFeb 13, 2025
BIMINI Biotech

Leiden, Zuid-Holland, The Netherlands

BIMINI Biotech is a startup that develops innovative therapeutic strategies for oncology.

BiotechnologyLife ScienceOncologyTherapeutics
SeedJan 13, 2025
Amount Raised: $3,064,696
Lomond Therapeutics

San Diego, California, United States

Lomond Therapeutics creates pharmacological platforms that target escape mutations.

BiopharmaBiotechnologyHealth CareMedical
Series UnknownNov 4, 2024
Amount Raised: $44,000,000
Polku Therapeutics

Helsinki, Southern Finland, Finland

Polku Therapeutics operates as a therapeutics company.

MedicalTherapeutics
Pre SeedSep 17, 2024
Amount Raised: $2,000,000
Brenig Therapeutics

Dover, Delaware, United States

Brenig Therapeutics develops therapies for neurodegenerative disorders.

Health CareMedicalTherapeutics
Series AJul 24, 2024
Amount Raised: $65,000,000
i2020 Accelerator

San Diego, California, United States

The i2020 Accelerator will provide funding and resources to companies in the areas of inflammation, oncology, CNS, and infectious diseases

Oncology
SeedJan 1, 2019
Context Therapeutics

Philadelphia, Pennsylvania, United States

Context Therapeutics is a clinical-stage biopharmaceutical company.

BiotechnologyHealth Care
Series UnknownNov 15, 2017
Viriom

San Diego, California, United States

Viriom is a clinical and commercial stage biotech developing drugs for treatment, prevention and cure of HIV and other infections.

BiotechnologyHealth CarePharmaceutical
Convertible NoteJun 6, 2017
Amount Raised: $2,560,000
TealTech MMO

San Diego, California, United States

A San Diego-based startup company, developed the Mobile Medical Office to offer healthcare providers a technology platform.

Health CareHealth DiagnosticsHome Health CaremHealth
Series UnknownMay 17, 2017
Amount Raised: $400,000